PhD, Boston University, Boston, MA (2010)
MPH, Boston University, Boston, MA (2006)
BS, University of Vermont, Burlington, VT (1999)
Post-Doctoral Research Fellow, Cancer Epidemiology, Harvard School of Public Health, Boston, MA (2010-2012)
Associate Professor, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT (2021-Present)
Associate Professor, Department of Biochemistry, University of Vermont, Burlington, VT (2021-Present)
Assistant Professor, Department of Biochemistry, University of Vermont, Burlington, VT (2014-2021)
Assistant Professor, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT (2013-2021)
Honorary Associate Professor of Oncology at Aarhus University in Aarhus, Denmark (October 2020)
Instructor, Department of Medicine, Harvard Medical School, Boston, MA (2011-2012)
Visiting Fellow, Department of Clinical Epidemiology, Aarhus University, Denmark
(2012-2013)
Associate Epidemiologist, Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA (2012-2013)
Scholar-in-Training Award, Molecular Epidemiology Working Group, American Association for Cancer Research (2012)
Clinical Research Student Loan Repayment Program, National Institutes of Health (2012)
Fred F. Kadlubar Memorial Scholar-in-Training Award, American Association for Cancer Research (2011)
Best Presentation by a Post-Doctoral Fellow, Harvard School of Public Health (2011)
Ahern TP, Collin LJ, Baurley JW, et al. Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients. Cancer Epidemiol Biomakers Prev. 2020:29(3):582-590. doi: 10.1158/1055-9965.EPI-19-0833
Ahern TP, Maclehose RF, Haines L, et al. Improving the Transparency of Meta-analyses with interactive web applications. BMJ Evid Based Med. Published online March 27, 2020. doi:10.1136/bmjebm-2019-111308
Ahern TP, Broe A, Lash TL, et al. Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study. J Clin Oncol. 2019;37(21):1800-1809. doi. 10.1200/JCO.18.02202
Borgquist S, Bjarnadottir O, Kimbung S, Ahern TP. Statins: a role in breast cancer therapy? J Intern Med. 2018;284(4):346-357. doi:10.1111/joim.12806
Ahern TP, Beck AH, Rosner BA, et al. Continuous measurement of breast tumor hormone receptor expression: a comparison of two computational pathology platforms. J Clin Pathol. 2017;70(5):428-434. doi: 10.1136/jclinpath-2016-204107
Ahern TP, Hertz DL, Damkier P, et al. Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity. Am J Epidemiol. 2017;185(2):75-85. doi: 10.1093/aje/kww178
Ahern TP, Sprague BL, Bissell MCS, et al. Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population. Cancer Epidemiol Biomakers Prev. 2017;26(6):938-944. doi: 10.1158/1055-9965.EPI-16-0801
Borgquist S, Giobbie-Hurder A, Ahern TP, et al. Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. J Clin Oncol. 2017;35(11):1179-1188. doi: 10.1200/JCO.2016.70.3116
Borgquist S, Tamimi RM, Chen WY, Garber JE, Eliassen AH, Ahern TP. Statin Use and Breast Cancer Risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev. 2016;25(1):201-206. doi: 10.1158/1055-9965. EPI-15-0654
Ahern TP, Cronin-Fenton DP, Lash TL, Sørensen HT, Ording AG, Hamilton-Dutoit SJ, Hellberg Y. Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study. Acta Oncol. 2016 Apr 8:1-8. [Epub ahead of print]. PMID: 27056567
Ahern TP, Horváth-Puhó E, Spindler KL, Sørensen HT, Ording AG, Erichsen R. Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort. Br J Cancer. 2016 Jan 12;114(1):96-102. doi: 10.1038/bjc.2015.406. Epub 2015 Dec 1. PMID: 26625005. PMCID: PMC4716535. [Available on 2017-01-12]
Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen P, Ejlertsen B, Sørensen HT. Low-dose aspirin, non-steroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence. Epidemiology. 2016 Mar 22. [Epub ahead of print]. PMID: 27007644
Borgquist S, Tamimi RM, Chen WY, Garber JE, Eliassen AH, Ahern TP. Statin Use and Breast Cancer Risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):201-6. doi: 10.1158/1055-9965.EPI-15-0654. PMID: 26762806. PMCID: PMC4842011. [Available on 2017-01-01]
Ahern TP, Horváth-Puhó E, Spindler KL, Sørensen HT, Ording AG, Erichsen R. Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort. Br J Cancer. 2016 Jan 12;114(1):96-102. doi: 10.1038/bjc.2015.406. Epub 2015 Dec 1. PMID: 26625005. PMCID: PMC4716535. [Available on 2017-01-12]
Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, et al. Opioids and breast cancer recurrence: A Danish population-based cohort study. Cancer. 2015 Oct 1;121(19):3507-14. doi: 10.1002/cncr.29532. Epub 2015 Jul 24. PMID: 26207518. PMCID: PMC4575607. [Available on 2016-10-01]
To view more publications, go to MyNCBI